Globenewswireยท2025-10-28 22:00Core Viewpoint - Baxter International, Inc. is facing a federal securities class action lawsuit due to safety concerns regarding its Novum IQ Large Volume Pump, which has been linked to serious patient injuries and deaths, leading to a significant decline in the company's stock price [4][5]. Summary by Sections Incident Overview - On April 7, 2025, safety issues regarding Baxter's Novum IQ Large Volume Pump emerged after a whistleblower reported inaccuracies in infusion [4]. - Baxter issued warning letters on April 24 and July 14, 2025, acknowledging risks of underinfusion and overinfusion, with reports of 79 serious injuries and two patient deaths [4]. - Following the announcement of a temporary pause in shipments on July 31, 2025, Baxter's stock price fell by $6.29, approximately 22.4%, from $28.05 to $21.76 [4]. Lawsuit Details - The lawsuit is on behalf of investors who purchased Baxter securities from February 23, 2022, to July 30, 2025 [5]. - Allegations include failure to disclose systemic defects in the Novum LVP, inadequate responses to reported malfunctions, and the heightened risk of halting new sales of the pumps [5].